Species Differences in Oxidative Drug Metabolism: Some Basic Considerations

作者: S. G. Al-Dabbagh , R. L. Smith

DOI: 10.1007/978-3-642-69132-4_31

关键词:

摘要: Perhaps one of the single most important developments in past 20 years understanding chemical toxicity has been realisation importance metabolic transformation this process. It is now widely appreciated that toxic effects many chemicals a function their metabolism rather than substance itself. Of central interest to toxicologist therefore an and significance The process itself however can be highly variable both between within animal species. For reason may have consider species strain differences when attempting extrapolate findings man safety evaluation twenty years, work on largely descriptive nature cataloguing differences. However, last few genetic diversity species, including man, terms biotransformation substrate preferences various multiple forms drug-metabolizing enzymes give better insight into metabolism. Furthermore, problem tempers expectations what hoped for extrapolation from other example, search metabolizes like will seen ill-conceived ill-advised. presentation deals with some fundamental aspects oxidative particular implications

参考文章(27)
Michael Davis, Roger Williams, J. Michael Tredger, Drug reactions and the liver Pitman Medical. ,(1981)
William B. Jakoby, Enzymatic basis of detoxication Academic Press. ,(1980)
Eugean Vanhorn, Elizabeth K. Weisburger, John H. Weisburger, Preston H. Grantham, Neal H. Steigbigel, David P. Rall, Activation and Detoxification of N-2-Fluorenylacetamide in Man Cancer Research. ,vol. 24, pp. 475- 479 ,(1964)
J.C. Ritchie, T.P. Sloan, J.R. Idle, R.L. Smith, Toxicological Implications of Polymorphic Drug Metabolism Novartis Foundation Symposia. ,vol. 76, pp. 219- 244 ,(2008) , 10.1002/9780470720592.CH12
S. G. AL-DABBAGH, J. R. IDLE, R. L. SMITH, Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains Journal of Pharmacy and Pharmacology. ,vol. 33, pp. 161- 164 ,(2011) , 10.1111/J.2042-7158.1981.TB13740.X
Adrian Küpfer, Sabah G. Al-Dabbagh, James C. Ritchie, Jeffrey R. Idle, Robert L. Smith, Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains. Biochemical Pharmacology. ,vol. 31, pp. 3193- 3199 ,(1982) , 10.1016/0006-2952(82)90549-4
R R Shah, N S Oates, J R Idle, R L Smith, J D Lockhart, Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. BMJ. ,vol. 284, pp. 295- 299 ,(1982) , 10.1136/BMJ.284.6312.295
Y. Fujii-Kuriyama, Y. Mizukami, K. Kawajiri, K. Sogawa, M. Muramatsu, Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver Proceedings of the National Academy of Sciences of the United States of America. ,vol. 79, pp. 2793- 2797 ,(1982) , 10.1073/PNAS.79.9.2793